PHASE-I STUDY USING COMBINATION OF HYDROXYUREA AND 5-AZACYTIDINE (NSC-102816)

被引：0
|
作者：
LOMEN, PL [1 ]
KHILANANI, P [1 ]
KESSEL, D [1 ]
机构：
[1] WAYNE STATE UNIV, SCH MED, DEPT ONCOL, HEMATOL SECT, DETROIT, MI 48201 USA
来源：
NEOPLASMA | 1980年 / 27卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：101 / 106
页数：6
相关论文
共 50 条
  • [1] PHASE-I STUDY USING COMBINATION OF HYDROXYUREA AND 5-AZACYTIDINE (NSC 102816)
    LOMEN, PL
    KHILANANI, P
    KESSEL, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 313 - 313
  • [2] PHASE I STUDY OF 5-AZACYTIDINE (NSC-102816)
    WEISS, AJ
    STAMBAUGH, JE
    MASTRANGELO, MJ
    LAUCIUS, JF
    BELLET, RE
    CANCER CHEMOTHERAPY REPORTS PART 1, 1972, 56 (03): : 413 - +
  • [3] PHASE I STUDY OF 5-AZACYTIDINE (NSC-102816)
    SHNIDER, BI
    BAIG, M
    COLSKY, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 16 (04): : 205 - 212
  • [4] TREATMENT OF ACUTE LEUKEMIA WITH 5-AZACYTIDINE (NSC-102816)
    MCCREDIE, KB
    BODEY, GP
    BURGESS, MA
    GUTTERMAN, JU
    RODRIGUEZ, V
    SULLIVAN, MP
    FREIREICH, EJ
    CANCER CHEMOTHERAPY REPORTS PART 1, 1973, 57 (03): : 319 - 323
  • [5] PHASE-1 STUDY OF TWICE WEEKLY 5-AZACYTIDINE (NSC-102816)
    VOGLER, WR
    ARKUN, S
    VELEZGAR.E
    CANCER CHEMOTHERAPY REPORTS PART 1, 1974, 58 (06): : 895 - 899
  • [6] PHASE 2 STUDY OF 5-AZACYTIDINE (NSC-102816) IN TREATMENT OF ADVANCED GASTROINTESTINAL CANCER
    MOERTEL, CG
    SCHUTT, AJ
    REITEMEIER, RJ
    HAHN, RG
    CANCER CHEMOTHERAPY REPORTS PART 1, 1972, 56 (05): : 649 - 652
  • [7] HEPATOTOXICITY OF 5-AZACYTIDINE (NSC-102816) (A CLINICAL AND PATHOLOGIC-STUDY)
    BELLET, RE
    MASTRANGELO, MJ
    ENGSTROM, PF
    CUSTER, RP
    NEOPLASMA, 1973, 20 (03) : 303 - 309
  • [8] CLINICAL TRIAL WITH SUBCUTANEOUSLY ADMINISTERED 5-AZACYTIDINE (NSC-102816)
    BELLET, RE
    MASTRANGELO, MJ
    ENGSTROM, PF
    STRAWITZ, JG
    WEISS, AJ
    YARBRO, JW
    CANCER CHEMOTHERAPY REPORTS PART 1, 1974, 58 (02): : 217 - 222
  • [9] ABSORPTION, DISTRIBUTION, AND EXCRETION OF 5-AZACYTIDINE (NSC-102816) IN MAN
    TROETEL, WM
    STAMBAUGH, JE
    WEISS, AJ
    LAUCIUS, JF
    MANTHEI, RW
    CANCER CHEMOTHERAPY REPORTS PART 1, 1972, 56 (03): : 405 - +
  • [10] PHASE-1 STUDY OF 5-AZACYTIDINE (NSC-102816) USING 24-HOUR CONTINUOUS INFUSION FOR 5 DAYS
    LOMEN, PL
    BAKER, LH
    NEIL, GL
    SAMSON, MK
    CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (06): : 1123 - 1126
12345